2012 Fiscal Year Final Research Report
Epigenome regulation for coupling of SAM synthesis and histone methylation
Project/Area Number |
23790321
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
General medical chemistry
|
Research Institution | Tohoku University |
Principal Investigator |
KATOH Yasutake 東北大学, 東北メディカル・メガバンク機構, 講師 (40397914)
|
Project Period (FY) |
2011 – 2012
|
Keywords | ゲノム医化学 / エピゲノム制御 / 転写制御 |
Research Abstract |
Histone and DNA methyltransferases utilized S-adenosyl-L-methioine (SAM, or AdoMet), a key intermediate of sulfur amino acid metabolism, as a donor of methyl group. SAM is biosynthesized by methionine adenosyltransferase (MAT) using two substrates, methionine and ATP. Three distinct forms of MAT (MATI, MATII and MATIII), encoded by two distinct genes (MAT1A and MAT2A), have been identified in mammals. MATII consists of α2 catalytic subunit encoded by MAT2A and β regulatory subunit encoded by MAT2B, but the physiological function of the β subunit is till unknown. MATII serves as a transcriptional corepressor in the oxidative stress response and forms the SAM-integrating transcription regulation module (SAMIT), affecting histone methyltransferase activities. However, the identities of genes regulated by MATIIα and β or its associated methyltransferases are unclear. My collaborators and I show that MATII represses the expression of cyclooxygenase 2 (COX-2) encoded by Ptgs2, by specifically interacting with histone H3K9 methyltransferase SETDB1, thereby promoting the trimethylation of H3K9 at the COX-2 locus. We discuss both gene-specific and epigenome-wide functions of MATII.
|